Donald Trump & AstraZeneca
12 shared events · Importance 5 · Last updated Aug 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Donald Trump: Donald Trump announced new tariffs on various imported goods, aiming to boost domestic manufacturing and reduce the budget deficit, despite warnings of increased inflation and harm to consumers.
AstraZeneca: AstraZeneca, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Business
Donald Trump: Donald Trump's administration has prioritized domestic investment, and AstraZeneca has already committed $50 billion to US manufacturing. The merger would likely need approval from his antitrust authorities.
AstraZeneca: AstraZeneca is the initiator of the merger talks, seeking to expand its US presence. Its shares fell over 7% on the news, reflecting investor skepticism about the deal's value and execution risk.
Aug 02, 2026 · 60 articles
Business
Donald Trump: Held off on strikes against Iran, easing oil prices. Pushed for lower rates.
AstraZeneca: Investors punished the stock over merger talks with Bristol Myers Squibb.
Jul 14, 2026 · 280 articles
Accidents
Donald Trump: Donald Trump>>>'s administration has been criticized for cuts to foreign aid and withdrawal from the World Health Organization>>>, which experts say have weakened global health response capabilities, though he has expressed concern about the outbreak and pledged some funding.
AstraZeneca: AstraZeneca was involved in the development of the COVID-19 vaccine platform that is now being considered for a Bundibugyo ebolavirus vaccine, showcasing its role in vaccine innovation.
May 18, 2026 · 505 articles
International
Donald Trump: Trump paused strikes to allow diplomacy, claiming 'good talks' with Iran, but warns of resuming attacks if negotiations fail. His approval ratings are weighed down by the prolonged conflict ahead of midterm elections.
AstraZeneca: AstraZeneca gained 1.3% after topping Q2 profit expectations.
Jul 08, 2026 · 472 articles
International
Donald Trump: US President; claims total control of strait and demands compensation from Iran, complicating negotiations.
AstraZeneca: Pharmaceutical company, whose stock gained on higher oil prices.
Jul 28, 2026 · 318 articles
Regulatory
Donald Trump: As President, Trump's administration has overseen vaccine policy changes and FDA leadership, influencing the regulatory climate.
AstraZeneca: AstraZeneca's flu vaccine portfolio could be affected by the entry of mFLUSIVA.
Aug 05, 2026 · 105 articles
Regulatory
AstraZeneca: AstraZeneca, like Pfizer, previously agreed to lower prescription drug costs for United States — Medicaid, contributing to the broader context of the Trump administration's efforts to control drug prices.
Nov 06, 2025 · 6 articles
International
AstraZeneca: AstraZeneca announced a significant investment of $15 billion in China through 2030 to expand its medicines manufacturing and research, demonstrating confidence in the Chinese market.
Jan 30, 2026 · 9 articles
International
AstraZeneca: AstraZeneca's CEO, Pascal Soriot, is part of the business delegation, suggesting potential for increased pharmaceutical and healthcare sector cooperation with China.
Jan 27, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Donald Trump and AstraZeneca interact across events, view sentiment trends, and discover connected entities.
Open Dashboard